ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,251 | -25.3% | 381,500 | -0.9% | 0.02% | -15.0% |
Q2 2023 | $13,726 | +84.6% | 384,900 | +31.5% | 0.02% | +100.0% |
Q1 2023 | $7,437 | -62.9% | 292,800 | -40.7% | 0.01% | -63.0% |
Q4 2022 | $20,029 | -99.9% | 493,800 | -34.6% | 0.03% | -22.9% |
Q3 2022 | $24,966,000 | +60.8% | 755,400 | +71.3% | 0.04% | +94.4% |
Q2 2022 | $15,528,000 | -11.2% | 441,000 | +16.0% | 0.02% | -14.3% |
Q1 2022 | $17,490,000 | +417.9% | 380,300 | +603.0% | 0.02% | +425.0% |
Q3 2021 | $3,377,000 | -77.2% | 54,100 | -69.8% | 0.00% | -78.9% |
Q2 2021 | $14,841,000 | -7.4% | 179,200 | -25.8% | 0.02% | -5.0% |
Q1 2021 | $16,020,000 | -16.4% | 241,600 | -63.7% | 0.02% | +5.3% |
Q1 2020 | $19,172,000 | -58.2% | 666,400 | -7.7% | 0.02% | -45.7% |
Q4 2019 | $45,815,000 | +147.2% | 722,300 | +9.8% | 0.04% | +118.8% |
Q3 2019 | $18,531,000 | -11.3% | 657,600 | -16.6% | 0.02% | -11.1% |
Q2 2019 | $20,903,000 | +568.5% | 788,800 | +362.9% | 0.02% | +500.0% |
Q1 2019 | $3,127,000 | +416.0% | 170,400 | -54.5% | 0.00% | +200.0% |
Q2 2017 | $606,000 | – | 374,164 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |